Nedosiran (DCR-PHXC) is an RNA interference (RNAi) targeting lactate dehydrogenase (LDH). Nedosiran represents an impactful potential therapeutic for primary hyperoxaluria (PH) with end-stage renal disease (ESRD). Nedosiran is a GalNAc-dsRNA conjugate[1]
Molecular Weight:
20929.6 (AS: 7427.0, SS: 13502.6)
CAS Number:
[2266591-83-5]
Formula:
C662H865F19N231O413P57S6
Target:
Small Interfering RNA (siRNA)
Application Notes:
Oligonucleotides
* VAT and and shipping costs not included. Errors and price changes excepted
